Structural Heart Devices Global Market - Forecast to 2022

  • ID: 3624720
  • Report
  • Region: Global
  • 232 Pages
  • IQ4I Research & Consultancy Pvt. Ltd
1 of 5
The Lack of Properly Trained Professionals Who Could Use the Advanced Surgical Instruments Is Severely Effecting Development of the Market

FEATURED COMPANIES

  • Abbott Laboratories U.S.
  • BioVentrix, Inc U.S.
  • Cardiosolutions, Inc U.S.
  • InterValve, Inc U.S
  • Medtronic PLC Ireland
  • MitrAssist Ltd. Israel
  • MORE


Structural heart devices has emerged as a new focus area of medical device manufacturers as the population of most developed and developing countries continue to become older and risk of cardiovascular diseases increase with aging.

The cardiovascular diseases which also include structural heart diseases have become leading cause of death. It is projected that, with newfound prosperity due to globalization and industrialization has led to changing lifestyle increasing risk of younger people developing cardiovascular diseases.

The increased interest has led to development of new technologies and devices that are less invasive and address the need of treatment of patients who are considered too weak to withstand the trauma of an open heart surgery.

The structural heart device market is classified based on type, end-users and geography. The structural heart device market by type is segmented into repair and replacement markets base on the type of procedure performed. The repair segment is further sub segmented into annuloplasty, valvuloplasty and Transcatheter mitral valve repair (TMVR).

The replacement segment is further segmented by technique into surgical valves and Transcatheter aortic valves replacement (TAVR). The surgical valve is sub-segmented as mechanical and tissue heart valves.

The structural heart devices end-user market is segmented into public and private hospitals based on location where the procedures are performed.

Finally, the structural heart devices market is classified by geographical regions:

- North America
- Europe
- Asia-pacific
- Rest of the World

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories U.S.
  • BioVentrix, Inc U.S.
  • Cardiosolutions, Inc U.S.
  • InterValve, Inc U.S
  • Medtronic PLC Ireland
  • MitrAssist Ltd. Israel
  • MORE
1 Executive Summary

2 Introduction
2.1 Key Take Aways
2.2 Report Description
2.3 Markets Covered
2.4 Stakeholders
2.5 Research Methodology
2.5.1 Market Size Estimation
2.5.2 Market Crackdown And Data Triangulation
2.5.3 Secondary Sources
2.5.4 Primary Sources
2.5.5 Key Data Points From Secondary Sources
2.5.6 Key Data Points From Primary Sources
2.5.7 Assumptions

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers And Opportunties
3.3.1.1 Prevalence Of Heart Valve Disorders Due To Aging Population
3.3.1.2 Technology Advancements And Growing Healthcare Budgetary Allocation
3.3.1.3 Demand For Minimally Invasive Surgery
3.3.2 Restraints And Threats
3.3.2.1 Strict Regulatory Requirements With High Cost Of Development
3.3.2.2 Lack Of Patient Awareness And Healthcare Infrastructure In Developing Countries
3.3.2.3 High Cost Of Devices And Procedure
3.3.3 Burning Issue
3.3.3.1 Lack Of Trained Professionals
3.4 Regulatory Affairs
3.4.1 U.S.
3.4.2 Europe
3.4.3 China
3.4.4 Canada
3.4.5 India
3.4.6 Japan
3.5 Reimbursement Scenario
3.6 Cpt Codes
3.7 Patent Trends
3.8 Technological Advancements
3.8.1 Tissue Engineering
3.8.2 Polymeric Heart Valves
3.8.3 Sutureless Aortic Valve Replacement (Su-Avr) System
3.8.4 Cardiac Or Ventricular Remodeling
3.8.5 Endoscopic Aortic Valve Replacement (Teavr) System
3.8.6 3-D Printed Model
3.9 Upcoming Technologies
3.10 Clinical Trials
3.11 Porter’S Five Force Analysis
3.11.1 Threat Of New Entrants
3.11.2 Threat Of Substitutes
3.11.3 Bargaining Power Of Suppliers
3.11.4 Bargaining Power Of Buyers
3.11.5 Rivalry Among Existing Competitors
3.12 Market Share Analysis By Major Players

4 Structural Heart Devices Global Market, By Type
4.1 Introduction
4.2 Structural Heart Repair Devices
4.2.1 Annuloplasty
4.2.2 Valvuloplasty
4.2.3 Transcatheter Mitral Valve Repair (Tmvr)
4.3 Structural Heart Replacement Valves
4.3.1 Introduction
4.3.2 Surgical Heart Valve Replacement
4.3.2.1 Mechanical Replacement Heart Valves
4.3.2.2 Biological Replacement Heart Valves (Tissue Valves)
4.3.3 Transcatheter Aortic Valve Replacement(Tavr)
4.3.4 Transcatheter Mitral Valve Replacement (Tmvr)**

5 Structural Heart Devices Global Market, By End-Users
5.1 Introduction
5.2 Public Hospitals
5.3 Private Hospitals

6 Regional Analysis
6.1 Introduction
6.2 North America
6.2.1 U.S.
6.3 Europe
6.4 Asia Pacific
6.4.1 India
6.4.2 China
6.5 Rest Of The World

7 Company Developments
7.1 Introduction
7.2 Approvals
7.3 Mergers & Acquisitions
7.4 New Product Launches
7.5 Agreements & Colloborations

8 Major Companies
8.1 Abbott Laboratories
8.1.1 Overview
8.1.2 Financials
8.1.3 Product Portfolio
8.1.4 Key Developments
8.1.5 Business Strategy
8.1.6 Swot Analysis
8.2 Boston Scientific Corpoartion
8.2.1 Overview
8.2.2 Financials
8.2.3 Product Portfolio
8.2.4 Key Developments
8.2.5 Business Strategy
8.2.6 Swot Analysis
8.3 Braile Biomedica
8.3.1 Overview
8.3.2 Financials
8.3.3 Product Portfolio
8.3.4 Key Developments
8.3.5 Business Strategy
8.3.6 Swot Analysis
8.4 Cryolife, Inc.
8.4.1 Overview
8.4.2 Financials
8.4.3 Product Portfolio
8.4.4 Key Developments
8.4.5 Business Strategy
8.4.6 Swot Analysis
8.5 Edwards Lifesciences Corp.
8.5.1 Overview
8.5.2 Financials
8.5.3 Product Portfolio
8.5.4 Key Developments
8.5.5 Business Strategy
8.5.6 Swot Analysis
8.6 Jenavalve Technology
8.6.1 Overview
8.6.2 Financials
8.6.3 Product Portfolio
8.6.4 Key Developments
8.6.5 Business Strategy
8.6.6 Swot Analysis
8.7 Lepu Medical Technology(Beijing) Co., Ltd.
8.7.1 Overview
8.7.2 Financials
8.7.3 Product Portfolio
8.7.4 Key Developments
8.7.5 Business Strategy
8.7.6 Swot Analysis
8.8 Livanova Plc (Sorin Group)
8.8.1 Overview
8.8.2 Financials
8.8.3 Product Portfolio
8.8.4 Key Developments
8.8.5 Business Strategy
8.8.6 Swot Analysis
8.9 Medtronic, Plc
8.9.1 Overview
8.9.2 Financials
8.9.3 Product Portfolio
8.9.4 Key Developments
8.9.5 Business Strategy
8.9.6 Swot Analysis
8.10 St. Jude Medical, Inc.
8.10.1 Overview
8.10.2 Financials
8.10.3 Product Portfolio
8.10.4 Key Developments
8.10.5 Business Strategy
8.10.6 Swot Analysis

List Of Tables

Table 1 Structural Heart Devices Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 2 Structural Heart Devices Global Market Revenue, By Type, (2014-2022) ($Mn)
Table 3 Structural Heart Repair Devices Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 4 Structral Heart Devices Repair Global Market Revenue, By Type, (2014-2022) ($Mn)
Table 5 Annuloplasty Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 6 Valvuloplasty Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 7 Tmvr Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 8 Structural Heart Replacement Devices Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 9 Structural Heart Devices Replacement Global Market Revenue, By Type, (2014-2022) ($Mn)
Table 10 Surgical Heart Valve Replacement Global Market Revenue, By Type, (2014-2022) ($Mn)
Table 11 Surgical Valve Replacement Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 12 Mechanical Replacement Heart Valve Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 13 Biological Replacement Heart Valve Global Market Revenue, By Geography, (2014-2022) ($Mn)
Table 14 Tavr Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 15 Structural Heart Devices Global Market Revenue, By End-User, (2014-2022) ($Mn)
Table 16 Public Hospitals Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 17 Private Hospitals Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 18 Structural Heart Devices Global Market Revenue, By Region, (2014-2022) ($Mn)
Table 19 North American Structural Heart Devices Market Revenue, By Type (2014-2022) ($Mn)
Table 20 North American Structural Heart Devices Repair Market Revenue, By Type, (2014-2022) ($Mn)
Table 21 North American Structural Heart Devices Replacement Market Revenue, By Type, (2014-2022) ($Mn)
Table 22 North American Structural Heart Surgical Replacement Market, By Type, (2014-2022) ($Mn)
Table 23 North American Structural Heart Devices Market Revenue, By End-Users, (2014-2022) ($Mn)
Table 24 European Structural Heart Devices Market Revenue, By Type, (2014-2022) ($Mn)
Table 25 European Structural Heart Devices Repair Market Revenue, By Type, (2014-2022) ($Mn)
Table 26 European Structural Heart Devices Replacement Market, By Type, (2014-2022) ($Mn)
Table 27 European Structural Heart Surgical Replacement Market, By Type, (2014-2022) ($Mn)
Table 28 European Structural Heart Devices Market Revenue, By End-Users, (2014-2022) ($Mn)
Table 29 Asia-Pacific Structural Heart Devices Market Revenue, By Type, (2014-2022) ($Mn)
Table 30 Asia-Pacific Structural Heart Devices Repair Market Revenue, By Type, (2014-2022) ($Mn)
Table 31 Asia-Pacific Structural Heart Replacement Market, By Type, (2014-2022) ($Mn)
Table 32 Asia-Pacific Structural Heart Devices Surgical Replacement Market, By Type, (2014-2022) ($Mn)
Table 33 Asia-Pacific Structural Heart Devices Market Revenue, By End-Users, (2014-2022) ($Mn)
Table 34 Rest Of The World Structural Heart Devices Market Revenue, By Type (2014-2022) ($Mn)
Table 35 Rest Of The World Structural Heart Devices Repair Market Revenue, By Type, (2014-2022) ($Mn)
Table 36 Rest Of The World Structural Heart Replacement Market, By Type, (2014-2022) ($Mn)
Table 37 Rest Of The World Structural Heart Devices Surgical Replacement Market, By Type, (2014-2022) ($Mn)
Table 38 Rest Of The World Structural Heart Devices Market Revenue, By End-Users, (2014-2022) ($Mn)
Table 39 Approvals (2013-2016)
Table 40 Mergers & Acquistions (2013-2016)
Table 41 New Product Launches (2013-2016)
Table 42 Agreement And Collaboration (2013-2016)
Table 43 Abbott Laboratories: Total Revenue And R&D Expenses, (2013-2015) ($Mn)
Table 44 Abbott Laboratories: Total Revenue By Segments, (2013-15) ($Mn)
Table 45 Abbott Laboratories: Total Revenue By Geography, (2013-2015) ($Mn)
Table 46 Boston Scientific Corporation: Total Revenue And R&D Expenses, (2013-2015) ($Mn)
Table 47 Boston Scientific Corporation: Total Revenue By Segments, (2013-2015) ($Mn)
Table 48 Boston Scientific Corporation: Cardiovascular, By Segmnets, (2013-2015) ($Mn)
Table 49 Boston Scientific Corporation: Total Revenue By Geography, (2013-2015) ($Mn)
Table 50 Cryolife, Inc.: Total Revenue And R&D Expenses, (2013-2015) ($Mn)
Table 51 Cryolife, Inc.: Total Revenue, By Segments, (2013-2015) ($Mn)
Table 52 Cryolife, Inc.: Preservation Services, By Sub-Segments, (2013-2015) ($Mn)
Table 53 Cryolife, Inc: Total Revenue, By Geography (2013-2015) ($Mn)
Table 54 Edwards Lifesciences Corp.: Total Revenue And R&D Expenses, (2013-2015) ($Mn)
Table 55 Edwards Lifesciences Corp.: Total Revenue, By Segments, (2013-2015) ($Mn)
Table 56 Edwards Lifesciences Corp.: Total Revenue, By Geography, (2013-2015) ($Mn)
Table 57 Livanova Plc: Total Revenue And R&D Expenses (2013-2015) ($Mn)
Table 58 Livanova Plc: Total Revenue, By Segments, (2013-2015) ($Mn)
Table 59 Livanova Plc: Cardiac Surgery Revenue, By Sub-Segments, (2013-2015) ($Mn)
Table 60 Livanova Plc: Total Revenue, By Geography, (2013-2015) ($Mn)
Table 61 Medtronic, Plc : Total Revenue And R&D Expenses, (2013-2015) ($Mn)
Table 62 Medtronic, Plc: Total Revenue, By Segments, (2013-2015) ($Mn)
Table 63 Medtronic, Plc: Cardiac & Vascular Revenue, By Sub-Segments, (2013-2015) ($Mn)
Table 64 Medtronic, Plc: Total Revenue, By Geography, (2013-2015) ($Mn)
Table 65 St. Jude Medical: Total Revenue And R&D Expenses, (2013-2015) ($Mn)
Table 66 St. Jude Medical: Total Revenue By Segments, (2013-2015) ($Mn)
Table 67 St. Jude Medical: Total Revenue By Geography, (2013-2015) ($Mn)

List Of Figures

Figure 1 Structural Heart Devices Global Market Revenue, By Geography, (2014-2022) ($Mn)
Figure 2 Structural Heart Devices Global Market: Research Approach
Figure 3 Structural Heart Devices Global Market: Top-Down And Bottom-Up Approach
Figure 4 Structural Heart Devices Global Market: Forecasting Model
Figure 5 Structural Heart Devices Global Market: Market Crackdown And Data Triangulation
Figure 6 Structural Heart Devices Global Market: Market Segmentation
Figure 7 Market Dynamics
Figure 8 Structural Heart Devices Global Market: Patent Filing By Major Players (2011-2015)
Figure 9 Structural Heart Devices Global Market: Porter’S Analysis
Figure 10 Structural Heart Devices Global Market Share Analysis, By Major Players, 2015 (%)
Figure 11 Structural Heart Devices Global Market Revenue, By Type, (2014-2022) ($Mn)
Figure 12 Structural Heart Devices Repair Global Market Revenue, By Type, (2014-2022)
Figure 13 Annuloplasty Global Market Revenue, By Region, (2014-2022) ($Mn)
Figure 14 Vavuloplasty Global Market Revenue, By Region, (2014-2022) ($Mn)
Figure 15 Tmvr Global Market Revenue, By Region, (2015 V’S 2022) ($Mn)
Figure 16 Structural Heart Devices Replacement Global Market Revenue, By Type, (2014-2022) ($Mn)
Figure 17 Surgical Valve Replacement Global Market Revenue, By Region, (2014-2022) ($Mn)
Figure 18 Biological Replacement Heart Valve Replacement Global Market Revenue, By Region, (2015 V’S 2022) ($Mn)
Figure 19 Tavr Global Market Revenue, By Region, (2015 V’S 2022) ($Mn)
Figure 20 Structural Heart Devices Global Market Revenue, By End-User, (2014-2022) ($Mn)
Figure 21 Structural Heart Devices Global Market Revenue, By Region, (2014-2022) ($Mn), Cagr (%)
Figure 22 North American Structural Heart Devices Market Size, By Repair, Replacement & End-Users, (2014-2022) ($Mn)
Figure 23 European Structural Heart Devices Market Size, By Repair, Replacement & End-Users, (2014-2022) ($Mn)
Figure 24 Asia-Pacific Structural Heart Devices Market Size, By Repair, Replacement & End-Users (2014-2022) ($Mn)
Figure 25 Rest Of The World Structural Heart Devices Market Size, By Repair, Replacement & End-Users, (2014-2022) ($Mn)
Figure 26 Key Growth Strategies (2013-2016)
Figure 27 Swot: Abbott Laboratories
Figure 28 Swot: Boston Scientific Corporation
Figure 29 Swot: Braile Biomedica
Figure 30 Swot: Cryolife, Inc
Figure 31 Swot: Edwards Lifesciences
Figure 32 Swot: Jenavalve Technology
Figure 33 Swot: Lepu Medical Technology Co., Ltd.
Figure 34 Swot: Livanova, Plc
Figure 35 Swot: Medtronic, Plc
Figure 36 Swot: St. Jude Medical
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Abbott Laboratories U.S.
- Abiomed Inc. U.S.
- Balton Sp. z o.o. Poland
- Bard Peripheral Vascular, Inc U.S
- BioVentrix, Inc U.S.
- Boston Scientific Corporation U.S.
- Braile bio medica Brazil
- Cardiac Dimensions, Inc. U.S.
- Cardiokinetix Inc U.S.
- Cardiosolutions, Inc U.S.
- Cephea valve technologies U.S.
- Colibri Heart Valve, LLC U.S.
- Coramaze Technologies GmbH Germany
- Cryo life Inc. U.S.
- Direct Flow Medical, Inc U.S.
- Edwards lifesciences Corporation U.S.
- Guided Delivery Systems, Inc. U.S.
- Heart Leaflet Technologies, Inc. U.S.
- HighLife Medical U.S.
- InterValve, Inc U.S
- JenaValve Technology GmbH Germany
- Labcor Laboratórios Ltda. Brazil
- Leman Cardiovascular Switzerland
- Lepu Medical Technology China
- Lifenet Health, Inc. U.S.
- LivaNova PLC UK
- Medtentia International Ltd Oy Finland
- Medtronic PLC Ireland
- MiCardia Corporation U.S.
- Micro Interventional Devices, Inc. U.S.
- MitrAssist Ltd. Israel
- Mitralign, Inc. U.S.
- NaviGate Cardiac Structures Inc. U.S.
- Neovasc Inc Canada
- NuMED, Inc. U.S
- Occlutech Germany
- Osypka AG Germany
- Secant Medical, Inc. U.S.
- St.Jude Medical Corporation U.S.
- Symetis SA Switzerland
- TTKChitra HeartValve India
- The Phoenix Cardiac device Pvt. Ltd. India
- Thubrikar Aortic Valve, Inc. U.S.
- TransCardiac Therapeutics, LLC U.S.
- Transcatheter Technologies GmbH Germany
- Valcare Medical, Inc. Israel
- Valtech Cardio, Ltd Israel
- Venus Medtech (Hangzhou) Inc. China
- W. L. Gore and Associates, Inc. U.S.
- Xuzhou Yatai Scientific CO.,LTD
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll